These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 29632289)
1. [Autoantibodies in Myasthenia Gravis]. Higuchi O Brain Nerve; 2018 Apr; 70(4):419-426. PubMed ID: 29632289 [TBL] [Abstract][Full Text] [Related]
2. Myasthenia gravis studied by monoclonal antibodies to the acetylcholine receptor. Tzartos SJ In Vivo; 1988; 2(1):105-10. PubMed ID: 2979808 [TBL] [Abstract][Full Text] [Related]
3. The role of antibodies in myasthenia gravis. De Baets M; Stassen MH J Neurol Sci; 2002 Oct; 202(1-2):5-11. PubMed ID: 12220686 [TBL] [Abstract][Full Text] [Related]
4. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis. Kawanami S; Tsuji R; Oda K Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620 [TBL] [Abstract][Full Text] [Related]
5. Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis. Howard FM; Lennon VA; Finley J; Matsumoto J; Elveback LR Ann N Y Acad Sci; 1987; 505():526-38. PubMed ID: 3479935 [TBL] [Abstract][Full Text] [Related]
6. Anti-acetylcholine receptor antibodies in myasthenia gravis: binding to membrane-bound Torpedo AChR. Koethe SM; DuPont BL; Calvo AM; Otterson G; McQuillen MP Ann N Y Acad Sci; 1987; 505():557-65. PubMed ID: 3479936 [No Abstract] [Full Text] [Related]
8. Expression of nicotinic acetylcholine receptor subunits in HEp-2 cells for immunodetection of autoantibody specificities in sera from Myasthenia gravis patients. George S; Noack M; Vanek M; Rentzsch J; Röber N; Conrad K; Roggenbuck D; Küpper JH Clin Hemorheol Microcirc; 2015; 61(2):385-96. PubMed ID: 26410878 [TBL] [Abstract][Full Text] [Related]
9. [Autoantibodies in myasthenia gravis]. Motomura M; Narita Masuda T Brain Nerve; 2013 Apr; 65(4):433-9. PubMed ID: 23568991 [TBL] [Abstract][Full Text] [Related]
10. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction. Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584 [TBL] [Abstract][Full Text] [Related]
11. Specific adsorbents for myasthenia gravis autoantibodies using mutants of the muscle nicotinic acetylcholine receptor extracellular domains. Lazaridis K; Evaggelakou P; Bentenidi E; Sideri A; Grapsa E; Tzartos SJ J Neuroimmunol; 2015 Jan; 278():19-25. PubMed ID: 25595248 [TBL] [Abstract][Full Text] [Related]
12. Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment. Pachner AR Yale J Biol Med; 1987; 60(2):169-77. PubMed ID: 3495075 [TBL] [Abstract][Full Text] [Related]
13. Antibodies to synthetic peptide (125-148) of the alpha-subunit of human nicotinic acetylcholine receptor in sera from patients with myasthenia gravis. Ohta M; Ohta K; Itoh N; Nishitani H; Hara H; Hayashi K Neurology; 1990 Nov; 40(11):1776-8. PubMed ID: 2234435 [TBL] [Abstract][Full Text] [Related]
16. A Novel Fusion Protein, AChR-Fc, Ameliorates Myasthenia Gravis by Neutralizing Antiacetylcholine Receptor Antibodies and Suppressing Acetylcholine Receptor-Reactive B Cells. Homma M; Uzawa A; Tanaka H; Kawaguchi N; Kanai T; Nakajima K; Narita M; Hara Y; Maruyama H; Ogawa Y; Himuro K; Kuwabara S Neurotherapeutics; 2017 Jan; 14(1):191-198. PubMed ID: 27677608 [TBL] [Abstract][Full Text] [Related]
17. [Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)]. de Crousaz G Ann Chir; 1980 Mar; 34(3):188-92. PubMed ID: 7369693 [No Abstract] [Full Text] [Related]
18. Myasthenia gravis: recognition of a human autoantigen at the molecular level. Protti MP; Manfredi AA; Horton RM; Bellone M; Conti-Tronconi BM Immunol Today; 1993 Jul; 14(7):363-8. PubMed ID: 8363727 [TBL] [Abstract][Full Text] [Related]
19. [Pseudo-internuclear ophthalmoplegia in myasthenia gravis]. Bogdan I; Crisanda V Oftalmologia; 2011; 55(3):70-3. PubMed ID: 22428294 [TBL] [Abstract][Full Text] [Related]